- mTOR inhibition of cardamonin on antiproliferation of A549 cells is involved in a FKBP12 independent fashion
Ying Tang et al, 2014, Life Sciences CrossRef - Toward chelerythrine optimization: Analogues designed by molecular simplification exhibit selective growth inhibition in non-small-cell lung cancer cells
Rosania Yang et al, 2016, Bioorganic & Medicinal Chemistry CrossRef - Reciprocal Negative Regulation between EGFR and DEPTOR Plays an Important Role in the Progression of Lung Adenocarcinoma
Xuefeng Zhou et al, 2016, Molecular Cancer Research CrossRef - Ovalitenone Inhibits the Migration of Lung Cancer Cells via the Suppression of AKT/mTOR and Epithelial-to-Mesenchymal Transition
Kittipong Sanookpan et al, 2021, Molecules CrossRef - Genetic alterations shaping tumor response to anti-EGFR therapies
Javier Vaquero et al, 2022, Drug Resistance Updates CrossRef - SHOC2 mediates the drug-resistance of triple-negative breast cancer cells to everolimus
Wenwen Geng et al, 2023, Cancer Biology & Therapy CrossRef - TGF-β1 induces erlotinib resistance in non-small cell lung cancer by down-regulating PTEN
Hua Shen et al, 2016, Biomedicine & Pharmacotherapy CrossRef - Alteration in Mir-21/PTEN Expression Modulates Gefitinib Resistance in Non-Small Cell Lung Cancer
Hua Shen et al, 2014, PLoS ONE CrossRef - Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells
Abderrahim El Guerrab et al, 2020, Scientific Reports CrossRef - Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer
Claudia Fumarola et al, 2014, Biochemical Pharmacology CrossRef - Co-treatment With Everolimus, an mTOR-Specific Antagonist, or Downregulation of ELK1 Enhances the Sensitivity of Pancreatic Cancer Cells to Genistein
Tianyu Li et al, 2021, Frontiers in Cell and Developmental Biology CrossRef